NE

New Frontier Minerals Limited

Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.

NFM | IL

Overview

Corporate Details

ISIN(s):
AU0000368748
LEI:
213800AG47SZ4DGATD33
Country:
Australia
Address:
45 VENTNOR AVENUE, 6005 WEST PERTH
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

New Frontier Minerals Limited is a mineral exploration company focused on identifying and developing multi-commodity assets with the potential for economic mining operations. The company applies a disciplined and structured exploration strategy to advance its projects. Its portfolio includes assets in Australia and Zambia, with exploration focused on commodities such as heavy rare earths, niobium, uranium, and copper. A key area of current activity is the Harts Range Heavy Rare Earths and Niobium Project in Australia's Northern Territory.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 08:10
Regulatory News Service
Drilling Campaign Approved at Harts Range Project
English 21.9 KB
2025-11-03 19:46
Regulatory News Service
Drill Targets Finalised at Harts Range Project
English 21.9 KB
2025-10-31 11:28
Pre-Annual General Meeting Information
Addendum to Notice of Annual General Meeting
English 25.2 KB
2025-10-29 11:54
Pre-Annual General Meeting Information
AGM Date & Closing Date for Director Nominations
English 12.7 KB
2025-10-09 08:00
Pre-Annual General Meeting Information
Notice of AGM
English 14.0 KB
2025-09-22 08:00
Annual Report
Final Results and Publication of Annual Report
English 615.1 KB
2025-09-22 08:00
Governance Information
Appendix G4 and Corporate Governance Statement
English 14.4 KB
2025-09-17 09:22
Delisting Announcement
Notification of Cessation of Securities
English 18.7 KB
2025-09-11 08:00
Regulatory News Service
Appointment of Drill Contractor
English 26.8 KB
2025-08-26 08:00
Report Publication Announcement
Appendix 3G
English 10.7 KB
2025-08-13 08:01
Board/Management Information
Change of Broker
English 13.4 KB
2025-08-13 08:00
Regulatory News Service
Bulk Sample from Cusp and new prospect identified
English 68.4 KB
2025-07-30 08:00
Quarterly Report
Quarterly Report
English 121.8 KB
2025-07-24 08:00
Regulatory News Service
Harts Range delivers further HRE Mineralisation
English 38.5 KB
2025-07-22 09:36
Major Shareholding Notification
Change of interests of substantial holder
English 59.3 KB

Automate Your Workflow. Get a real-time feed of all New Frontier Minerals Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for New Frontier Minerals Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for New Frontier Minerals Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.